CLINICAL_TRIALS
trial_result
· 2025-07-11
Clinical Trial Update: Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy [Phase 3]
Summary
A Phase 3 study evaluating adjunctive ganaxolone (GNX) versus placebo for tuberous sclerosis complex-related epilepsy has completed and results have been posted…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Marinus Pharmaceuticals | Conditions: Tuberous Sclerosis Complex | Phase 3 | Status: COMPLETED | Results posted: 2025-07-11